Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01678300 · ClinicalTrials.gov registry record
Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 70
- Enrollment target
NCT01678300 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 70 participants.
The verdict
NCT01678300 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The purpose of this protocol is: 1. To quantify the prevalence of adherence to topical mesalamine in patients with UC 2. To describe the determinants of medication adherence in patients with UC prescribed topical mesalamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01678300
The ClinicalTrials.gov registry entry for NCT01678300 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01678300 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01678300 about?
NCT01678300 is a clinical study titled "Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)". The purpose of this protocol is: 1. To quantify the prevalence of adherence to topical mesalamine in patients with UC 2. To describe the determinants of medication adherence in patients with UC prescribed topical mesalamine
What is the current status of trial NCT01678300?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2012-08. Estimated completion is 2015-11.
Who is sponsoring clinical trial NCT01678300?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.